banner
Raltitrexed reagent, Raltitrexed-PEG-lactosyl, PEG 350 Da, Purity ≥95%
Inquiry

Cat. No.: X25-02-ZQ650

Raltitrexed reagent, Raltitrexed-PEG-lactosyl, PEG 350 Da, Purity ≥95%

Synonym: Raltitrexed-lactosyl; Lactosyl-PEG-Raltitrexed

img
Product Size
100 mg; 250 mg; 500 mg; 1 g; 5 g; 25 g
Price
Datasheet
MSDS
Properties
Description
This high-purity conjugate combines the folate analog raltitrexed with lactosyl groups via a short 350 Da PEG linker for targeted drug delivery research.
Molecular Weight
PEG 350 Da
Glycan Name
Lactosyl
Source
Chemical synthesis
Functional Group
Raltitrexed
Form
Solid or powder
Purity
≥95%
Solubility
Raltitrexed-PEG-lactosyl is soluble in a wide range of organic solvents, such as DCM, DMF, and DMSO, and shows excellent solubility in water.
Identity
Confirmed by NMR.
Applications
This reagent is used in oncology research to develop targeted chemotherapy agents, employing short PEG linkers for selective tumor cell uptake.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.

Contact Us

  • For research and manufacturing partners only. Not intended for (direct) human or veterinary use.
Copyright © CD BioGlyco. All rights reserved.